Zhejiang Changxin Technology: The payment for strategic placement and the placement work have been completed; the effective subscription rate for off-market A-category investors exceeded 87%.

robot
Abstract generation in progress

Deep Tide TechFlow news: On July 20, Changxin Technology released an announcement regarding the preliminary results of the off-exchange (offline) initial placements and the online lottery results for its first public offering of shares and its listing on the STAR Market, announcing that the payment and placement work for this offering’s strategic placement has been completed. All investors participating in the strategic placement participated in this strategic placement as committed. The initial quantity for this offering’s strategic placement was 334,404.4304 ten thousand shares, accounting for 50.00% of the initial offering size. It is also approximately 43.48% of the total number of shares after the over-allotment option is exercised in full. The subscription funds pledged by the investors participating in the strategic placement have been fully remitted, within the prescribed time, to the bank accounts designated by CICC. After the strategic placement reallocation and before the online-offline reallocation mechanism was triggered, and after the over-allotment was enabled, the initial online offering size was 334,900.1000 ten thousand shares, which is approximately 55.59% of the total offering size after deducting the final strategic placement quantity following the exercise of the over-allotment option.

A total of 10,907 valid bids, managed by 285 offline investors, all conducted offline subscriptions in accordance with the requirements of the “Issuance Announcement.” The number of valid offline subscription shares was 123,822,210 ten thousand shares, including 107,837,530 ten thousand shares for A-category investors, representing 87.09% of the valid offline subscription quantity; 15,984,680 ten thousand shares for B-category investors, representing 12.91% of the valid offline subscription quantity.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned